AFJKR

Aimei Health Technology Co., Ltd

USD

Set alert

Price alert · AFJKR

All alert types
0.15 USD 0.00 0.00%
As of Oct 28, 2026 Extended hours 0.12 -20.00%
Bid
0.10 × —
Ask
0.16 × 10
0.15 Day range 0.15
0.15 52-week range 0.15
YTD
0.00%
1 year
0.00%
Open
0.1595
Prev close
0.15
Mkt cap
1.10M
Vol
1
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.15
High
0.15
Forward P/E
0.00
Beta
0.00
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.00
200-d avg
0.00
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for AFJKR has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.91 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 4
  • P/B 1

Valuation

P/E 377×
FY 2023: 534×FY 2024: 38.2×FY 2025: 377×
FY 2023 5y median 377× FY 2025
P/S 0.0×
FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2023 5y median 0.0× FY 2025
P/B 32.2×
FY 2023: 1.3×FY 2024: 1.3×FY 2025: 32.2×
FY 2023 5y median 1.3× FY 2025
P/FCF -458×
FY 2023: 0.0×FY 2024: -144×FY 2025: -458×
FY 2023 5y median -144× FY 2025
EV/EBITDA -312×
FY 2023: 531×FY 2024: -90.9×FY 2025: -312×
FY 2023 5y median -90.9× FY 2025
EV/Sales 0.0×
FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2023 5y median 0.0× FY 2025
FCF Yield -0.2%
FY 2023: 0.0%FY 2024: -0.7%FY 2025: -0.2%
FY 2023 5y median -0.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2023 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2023 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2023 5y median 0.0% FY 2025
ROE 13.2%
FY 2023: 0.2%FY 2024: 3.5%FY 2025: 13.2%
FY 2023 5y median 3.5% FY 2025
ROIC -7.8%
FY 2023: -0.0%FY 2024: -1.5%FY 2025: -7.8%
FY 2023 5y median -1.5% FY 2025
ROA 8.8%
FY 2023: 0.2%FY 2024: 3.5%FY 2025: 8.8%
FY 2023 5y median 3.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2023 FY 2025
Operating Income 21.5%
FY 2023: 0.0%FY 2024: -3642.2%FY 2025: 21.5%
FY 2023 FY 2025
EPS (diluted) -39.3%
FY 2023: 0.0%FY 2024: 1373.7%FY 2025: -39.3%
FY 2023 FY 2025
Free Cash Flow 15.9%
FY 2023: 0.0%FY 2024: 0.0%FY 2025: 15.9%
FY 2023 FY 2025

Financial Health

Current Ratio 0.0×
FY 2023: 23.4×FY 2024: 0.0×FY 2025: 0.0×
FY 2023 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2023: 23.4×FY 2024: 0.0×FY 2025: 0.0×
FY 2023 5y median 0.0× FY 2025
Debt / Equity 0.3×
FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.3×
FY 2023 5y median 0.0× FY 2025
Net Debt / EBITDA -2.4×
FY 2023: -3.4×FY 2024: -0.2×FY 2025: -2.4×
FY 2023 5y median -2.4× FY 2025
Interest Coverage 0.0×
FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2023 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2023 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31